• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Books » GCP Questions, FDA Answers, 2023 Edition
GCP Questions, FDA Answers 2023 Edition

GCP Questions, FDA Answers, 2023 Edition

$397.00
Books

Product Details

Get answers to your most important clinical trial compliance questions directly from the regulatory source. Learn from the FDA’s Good Clinical Practice Program (GCPP) how to conduct safe, effective and compliant trials that can win approval of your new drug or device. The newest edition of GCP Questions, FDA Answers is here.

This all-new edition collates more than 100 questions and answers that get right to the heart of your role as a clinical trial professional. Our 2023 edition addresses many of the challenges you may face in your clinical research, including:

  • Using virtual monitoring to supplement on-site visits
  • Reconsent requirement in case of a change in principal investigator
  • When an investigator needs to complete and sign a new Form 1572
  • Listing local laboratories on the Form 1572
  • Using diagnostic centers for standard-of-care procedures
  • Reporting a serious breach of GCP or protocol during the trial
  • Monitoring payments to subjects
  • Clinical trial translation requirements
  • Storage of investigational medications
  • Maintaining old documents in the investigator site file
  • Maintaining documentation after a site permanently shuts down

In addition to the extensive Q&A collection, the 2023 edition provides the complete text of essential documents most often recommended by the FDA in its answers, such as:

  • ICH E6(R2) — Good Clinical Practice
  • A Risk-Based Approach to Monitoring of Clinical Investigations: Questions and Answers
  • Investigator Responsibilities — Protecting the Rights, Safety and Welfare of Study Subjects
  • Frequently Asked Questions — Statement of Investigator (Form FDA 1572)
  • Electronic Source Data in Clinical Investigations
  • Safety Reporting Requirements for INDs and BA/BE (Bioavailability/Bioequivalence) Studies
  • Financial Disclosure by Clinical Investigators

Gain peace of mind in your next clinical trial with answers to your most pressing compliance questions, and answers to those you might not have even thought of yet, in GCP Questions, FDA Answers.

Who Will Benefit

  • Researchers/investigators
  • Clinical trial research directors
  • Clinical trial project managers
  • CRAs
  • CRCs
  • Consultants

PDF

$397.00
Add to Cart

ISBN-13:
978-1-60430-216-5

Publication date:
August 2023

Page count:
794


Our Guarantee
Not satisfied with your publication? For the PDF version, you must notify CenterWatch within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.

  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing